Skip to content

Biogen BIIB Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin75.5%-0.1pp75.7%-0.4pp75.2%-0.3pp75.4%-0.1pp75.6%+0.5pp
Net margin14.3%-0.8pp13.6%-3.3pp16%-0.8pp15.3%+3.3pp15.1%+3.0pp
EBITDA margin27%+0.1pp26.2%-2.4pp28.5%+0.1pp27.4%+5.8pp26.9%+5.9pp
Free cash flow margin24.4%-0.4pp20.7%-7.4pp22.9%+2.1pp19.8%+3.1pp24.8%+9.9pp
Returns
Return on equity8%-1.2pp7.7%-2.7pp9.3%-1.2pp9.1%+1.5pp9.2%+1.1pp
Return on assets4.9%-0.5pp4.7%-1.3pp5.6%-0.1pp5.6%+1.1pp5.4%+0.9pp
Return on invested capital7.8%-0.4pp7%-1.5pp8.8%-0.3pp8%+1.2pp8.1%+1.2pp
Efficiency
Asset turnover0.3×0.0×0.3×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Inventory turnover19×-3.6×20.1×-6.2×19.4×-11.8×18.8×-8.0×22.6×-12.6×
Liquidity
Current ratio3.1×+1.6×2.7×+1.3×2.7×+1.5×2.5×+0.2×1.4×-0.7×
Quick ratio+1.6×2.6×+1.3×2.7×+1.4×2.5×+0.2×1.4×-0.6×
Cash ratio1.1×+0.6×0.9×+0.5×1.2×+0.9×0.9×+0.3×0.5×+0.2×
Leverage
Debt-to-equity0.4×+0.1×0.4×0.0×0.4×+0.1×0.4×0.0×0.3×-0.2×
Debt-to-assets0.2×0.0×0.2×0.0×0.2×+0.1×0.2×0.0×0.2×-0.1×
Net debt / EBITDA1.2×+0.3×1.4×-0.2×-0.2×1.4×-0.9×0.9×-1.9×
Per Share
Book value per share$125.69+8.5%$124.11+8.3%$123.78+10.5%$120.20+10.4%$115.82+11.1%
Valuation
Market capitalization$26.91B+34.3%$25.82B+15.9%$20.54B-27.3%$18.51B-45.2%$20.03B-36.1%
Enterprise value$30.08B+34.9%$29.47B+10.7%$23.27B-26.0%$22.34B-42.0%$22.3B-39.7%
Price / earnings18.9×+5.4×19.2×+5.6×12.8×-4.7×12.1×-17.0×13.5×-13.3×
Price / sales2.7×+0.7×2.6×+0.3×-0.9×1.9×-1.6×-1.2×
Price / book1.4×+0.3×1.4×+0.1×1.1×-0.6×-1.1×1.2×-0.9×
EV / EBITDA11.2×+2.8×11.4×+1.8×8.1×-3.4×8.2×-10.3×8.4×-9.7×
EV / sales+0.8×+0.2×2.3×-1.0×2.2×-1.7×2.3×-1.6×
Free cash flow yield9%-3.2pp7.9%-4.3pp11.2%+4.1pp10.7%+5.9pp12.2%+7.6pp
Earnings yield5.3%-2.1pp5.2%-2.1pp7.8%+2.1pp8.3%+4.8pp7.4%+3.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Biogen's profit margins?
Biogen (BIIB) runs a 75.5% gross margin and a 22.9% operating margin, with a 14.3% net margin.
Where do Biogen's ratios come from?
Every ratio is computed from Biogen's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.